Edwards Lifesciences officer may sell $2.9M in stock

Rhea-AI Filing Summary

Edwards Lifesciences Corp (EW) received a notice under Rule 144 that officer Daveen Chopra may sell up to 31,800 shares of Edwards Lifesciences common stock through broker Charles Schwab & Co., Inc. The planned sale is associated with an Employee Stock Option Exercise and is listed to occur on 08/26/2026 on the NYSE.

Key Figures

Shares to be sold under Rule 144: 31,800 shares of common stock Aggregate market value: $2,894,440.00 Shares outstanding of the class: 576,400,000 shares +1 more

4 metrics

Shares to be sold under Rule 144 31,800 shares of common stock Maximum shares listed in the Securities To Be Sold section

Aggregate market value $2,894,440.00 Value associated with 31,800 common shares in the Securities Information section

Shares outstanding of the class 576,400,000 shares Total number of shares of the common stock class listed in Securities Information

Planned transaction date 08/26/2026 Date listed for the Employee Stock Option Exercise and broker payment

Key Terms

Rule 144, Employee Stock Option Exercise, Broker Payment for Cashless Exercise

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Employee Stock Option Exercise financial

"Common | 08/26/2026 | Employee Stock Option Exercise |"

Broker Payment for Cashless Exercise financial

"31800 | 08/26/2026 | Broker Payment for Cashless Exercise"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for EW disclose about planned share sales?

The filing discloses that officer Daveen Chopra may sell up to 31,800 shares of Edwards Lifesciences common stock under Rule 144, in connection with an Employee Stock Option Exercise, with a listed transaction date of 08/26/2026.

Who is selling Edwards Lifesciences (EW) shares in this Form 144?

The notice states that Daveen Chopra, identified as an Officer of Edwards Lifesciences Corp, is the person for whose account the securities are to be sold, with sales aggregated as required under Rule 144.

How many Edwards Lifesciences (EW) shares are covered by this Rule 144 notice?

The Rule 144 notice covers up to 31,800 shares of Edwards Lifesciences common stock to be sold in connection with an Employee Stock Option Exercise and a Broker Payment for Cashless Exercise on 08/26/2026.

What is the aggregate market value of the EW shares in this Form 144?

The securities information section lists an aggregate market value of $2,894,440.00 for the 31,800 Edwards Lifesciences common shares referenced in the Rule 144 notice.

Which broker is involved in the Edwards Lifesciences (EW) Form 144 transaction?

The common stock is shown as held at Charles Schwab & Co., Inc., with the planned sale described as a Broker Payment for Cashless Exercise linked to an Employee Stock Option Exercise on 08/26/2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/26/2026 - 04:03 PM EDT Accepted by SEC EDGAR 08/26/2026 - 04:01 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001740963
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Edwards Lifesciences Corp
SEC File Number	001-15525
Address of Issuer	ONE EDWARDS WAY IRVINE CALIFORNIA 92614
Phone	9492502500
Name of Person for Whose Account the Securities are To Be Sold	Chopra Daveen
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	31800	2894440.00	576400000	08/26/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/26/2026	Employee Stock Option Exercise	EDWARDS LIFESCIENCES CORPORATION			31800	08/26/2026	Broker Payment for Cashless Exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/26/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Daveen Chopra
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)